Mechanisms of Graft Rejection After Lung Transplantation

Overview

Journal Curr Opin Organ Transplant

Specialty General Surgery

Date 2016 Nov 19

PMID 27861263

Citations 14

Authors

Hsi-Min Hsiao

Davide Scozzi

Jason M Gauthier

Daniel Kreisel

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To date, outcomes after lung transplantation are far worse than after transplantation of other solid organs. New insights into mechanisms that contribute to graft rejection and tolerance after lung transplantation remain of great interest. This review examines the recent literature on the role of innate and adaptive immunity in shaping the fate of lung grafts.

Recent Findings: Innate and adaptive immune cells orchestrate allograft rejection after transplantation. Innate immune cells such as neutrophils are recruited to the lung graft early after reperfusion and subsequently promote allograft rejection. Although it is widely recognized that CD4 T lymphocytes in concert with CD8 T cells promote graft rejection, regulatory Foxp3 CD4 T, central memory CD8 T cells, and natural killer cells can facilitate tolerance.

Summary: This review highlights interactions between innate and adaptive immune pathways and how they contribute to lung allograft rejection. These findings lay a foundation for the design of new therapeutic strategies that target both innate and adaptive immune responses.

Citing Articles

Extracorporeal membrane oxygenation vs cardiopulmonary bypass in lung transplantation: an updated meta-analysis.

Noleto da Nobrega Oliveira R, Passos F, Pessoa B Gen Thorac Cardiovasc Surg. 2024; 73(3):137-146.

PMID: 39708283 DOI: 10.1007/s11748-024-02114-x.

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.

Bery A, Belousova N, Hachem R, Roux A, Kreisel D Transplantation. 2024; 109(3):454-466.

PMID: 39104003 PMC: 11799353. DOI: 10.1097/TP.0000000000005162.

Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells-Therapeutic Window for Interleukin-10.

Nykanen A, Mariscal A, Duong A, Ali A, Takahagi A, Bai X Cells. 2024; 13(10.

PMID: 38786082 PMC: 11119666. DOI: 10.3390/cells13100859.

Lung transplantation in children.

Ehrsam J, Meier Adamenko O, Pannu M, Schob O, Inci I Turk Gogus Kalp Damar Cerrahisi Derg. 2024; 32(Suppl1):S119-S133.

PMID: 38584780 PMC: 10995684. DOI: 10.5606/tgkdc.dergisi.2024.25806.

Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis.

Binda M, Moccaldi B, Civieri G, Cuberli A, Doria A, Tona F Int J Mol Sci. 2024; 25(4).

PMID: 38396976 PMC: 10889602. DOI: 10.3390/ijms25042299.

References

Shen H, Song Y, Colangelo C, Wu T, Bruce C, Scabia G . Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest. 2011; 122(1):383-7. PMC: 3248290. DOI: 10.1172/JCI58344. View

Yamada M, Ueda M, Naruko T, Tanabe S, Han Y, Ikura Y . Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int. 2001; 59(4):1374-81. DOI: 10.1046/j.1523-1755.2001.0590041374.x. View

Li W, Carper K, Zheng X, Kuhr C, Reyes J, Liang Y . The role of Foxp3+ regulatory T cells in liver transplant tolerance. Transplant Proc. 2006; 38(10):3205-6. DOI: 10.1016/j.transproceed.2006.10.093. View

Ochando J, Yopp A, Yang Y, Garin A, Li Y, Boros P . Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol. 2005; 174(11):6993-7005. DOI: 10.4049/jimmunol.174.11.6993. View

Constant S, Brogdon J, Piggott D, Herrick C, Visintin I, Ruddle N . Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest. 2002; 110(10):1441-8. PMC: 151814. DOI: 10.1172/JCI16109. View

Lin Y, Chen L, Li W, Fang J . Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med. 2015; 9(4):1537-1541. PMC: 4353799. DOI: 10.3892/etm.2015.2290. View

Laubach V, Sharma A . Mechanisms of lung ischemia-reperfusion injury. Curr Opin Organ Transplant. 2016; 21(3):246-52. PMC: 4861054. DOI: 10.1097/MOT.0000000000000304. View

Trambley J, Bingaman A, Lin A, Elwood E, Waitze S, Ha J . Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest. 1999; 104(12):1715-22. PMC: 409885. DOI: 10.1172/JCI8082. View

Wingard C, Walters D, Cathey B, Hilderbrand S, Katwa P, Lin S . Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology. 2010; 5(4):531-45. PMC: 3208763. DOI: 10.3109/17435390.2010.530004. View

10.

Banga A, Han Y, Wang X, Hsieh F . Mast cell phenotypes in the allograft after lung transplantation. Clin Transplant. 2016; 30(7):845-51. PMC: 5735837. DOI: 10.1111/ctr.12758. View

11.

Gelman A, Li W, Richardson S, Zinselmeyer B, Lai J, Okazaki M . Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol. 2009; 182(7):3969-73. PMC: 3760174. DOI: 10.4049/jimmunol.0803514. View

12.

Adams A, Williams M, Jones T, Shirasugi N, Durham M, Kaech S . Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003; 111(12):1887-95. PMC: 161424. DOI: 10.1172/JCI17477. View

13.

Thaunat O, Patey N, Morelon E, Michel J, Nicoletti A . Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr Opin Immunol. 2006; 18(5):576-9. DOI: 10.1016/j.coi.2006.07.006. View

14.

Barker C, Billingham R . The role of afferent lymphatics in the rejection of skin homografts. J Exp Med. 1968; 128(1):197-221. PMC: 2138504. DOI: 10.1084/jem.128.1.197. View

15.

Altemeier W, Liles W, Villagra-Garcia A, Matute-Bello G, Glenny R . Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice. PLoS One. 2013; 8(10):e77123. PMC: 3795647. DOI: 10.1371/journal.pone.0077123. View

16.

Liu Y, Li W, Luehmann H, Zhao Y, Detering L, Sultan D . Noninvasive Imaging of CCR2 Cells in Ischemia-Reperfusion Injury After Lung Transplantation. Am J Transplant. 2016; 16(10):3016-3023. PMC: 5143208. DOI: 10.1111/ajt.13907. View

17.

Greenland J, Xu X, Sayah D, Liu F, Jones K, Looney M . Mast cells in a murine lung ischemia-reperfusion model of primary graft dysfunction. Respir Res. 2014; 15:95. PMC: 4151192. DOI: 10.1186/s12931-014-0095-0. View

18.

Krustrup D, Madsen C, Iversen M, Engelholm L, Ryder L, Andersen C . The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection. Transpl Immunol. 2013; 29(1-4):71-5. DOI: 10.1016/j.trim.2013.08.002. View

19.

Prop J, Wildevuur C, Nieuwenhuis P . Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts. Transplantation. 1985; 40(2):126-31. DOI: 10.1097/00007890-198508000-00003. View

20.

Li W, Bribriesco A, Nava R, Brescia A, Ibricevic A, Spahn J . Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis. Mucosal Immunol. 2012; 5(5):544-54. PMC: 3425714. DOI: 10.1038/mi.2012.30. View